5-alpha reductase inhibitors - Open Access .click

Results 231 to 240 of about 46,559 (243)

Some of the next articles are maybe not open access.

[5-alpha reductase inhibitors and prostate cancer prevention].

Zhonghua nan ke xue = National journal of andrology, 2013
5-alpha reductase inhibitors decrease the level of dihydrotestosterone (DHT) by inhibiting 5-alpha reductase. Trials on 5-alpha reductase inhibitors in prostate cancer prevention showed that they could significantly decrease the incidence of prostate cancer, but meanwhile increase high-grade cases as well.
openaire +1 more source

Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: Effect of 5-alpha reductase inhibitors

Prostate, 1995
S Prahalada
exaly

Alpha‐1 adrenergic antagonists, 5‐alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta‐analysis of urodynamic studies

Neurourology and Urodynamics, 2018
Ferdinando Fusco +2 more
exaly

Finasteride and the 5-Alpha Reductase Inhibitors

Bilal F. Hamzeh +3 more
openaire +1 more source

Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors

European Urology, 2007
Olivier Cussenot +2 more
exaly

[Alpha blockers and 5-alpha reductase inhibitors].

Pharmazie in unserer Zeit, 2008
Ulrike, Holzgrabe, Andrea, Sinz
openaire +1 more source

Establishing the clinical and economic benefits of adherence to 5-alpha reductase inhibitors in benign prostatic hyperplasia: an assessment of Medicare and Medicaid patients

Expert Opinion on Pharmacotherapy, 2012
exaly